4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000005
CEO bought 65,500 shares at an average $0.03 ($1,774)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Collier Alan Brian CEO | 2019-01-17 | Purchase | +5,000 | $0.03 | $149 | 20,812,623 | D: show line 1 in the form |
| Collier Alan Brian CEO | 2019-01-17 | Purchase | +5,000 | $0.03 | $148 | 20,817,623 | D: show line 2 in the form |
| Collier Alan Brian CEO | 2019-01-17 | Purchase | +5,000 | $0.03 | $148 | 20,822,623 | D: show line 3 in the form |
| Collier Alan Brian CEO | 2019-01-22 | Purchase | +500 | $0.03 | $13 | 20,823,123 | D: show line 4 in the form |
| Collier Alan Brian CEO | 2019-01-22 | Purchase | +10,000 | $0.03 | $260 | 20,833,123 | D: show line 5 in the form |
| Collier Alan Brian CEO | 2019-01-22 | Purchase | +5,000 | $0.03 | $130 | 20,838,123 | D: show line 6 in the form |
| Collier Alan Brian CEO | 2019-01-22 | Purchase | +5,000 | $0.03 | $130 | 20,843,123 | D: show line 7 in the form |
| Collier Alan Brian CEO | 2019-01-22 | Purchase | +5,000 | $0.03 | $130 | 20,848,123 | D: show line 8 in the form |
| Open-market purchases · 65,500 sh · avg $0.03 · $1,774 | |||||||
Loading xslF345X03/primary_doc.xml…